Journal of Biological Chemistry · 2006 · 21 citations · 27 references
Life SciencesImmunologyPharmacologyCell SignalingImmunopharmacologyImmunotherapyCytokine BiologyCytokine RegulationCytokine SignalingCytokine TherapyCytokine-based TherapyCytokine BlockadeCytokine NeutralizationFusion Regulatory ProteinsInterleukin-6 InhibitionInterleukin-6 InhibitorsInterleukin-6 Mediated RegulationReceptorsRecombinant Fusion Proteins
Although fusion proteins of the extracellular parts of receptor subunits termed cytokine traps turned out to be promising cytokine inhibitors for anti-cytokine therapies, their mode of action has not been analyzed. We developed a fusion protein consisting of the ligand binding domains of the IL-6 receptor subunits IL-6Ralpha and gp130 that acts as a highly potent IL-6 inhibitor. Gp130 is a shared cytokine receptor also used by the IL-6-related cytokines oncostatin M and leukemia inhibitory factor. In this study, we have shown that the IL-6 receptor fusion protein (IL-6-RFP) is a specific IL-6 inhibitor that does not block oncostatin M or leukemia inhibitory factor. We characterized the complex of IL-6-RFP and fluorescently labeled IL-6 (YFPIL-6) by blue native PAGE and gel filtration. A 2-fold molar excess of IL-6-RFP over IL-6 was sufficient to entirely bind IL-6 in a complex with IL-6-RFP. As shown by treatment with urea and binding competition experiments, the complex of IL-6 and IL-6-RFP is more stable than the complex of IL-6, soluble IL-6Ralpha, and soluble gp130. By live cell imaging, we have demonstrated that YFP-IL-6 bound to the surface of cells expressing gp130-CFP is removed from the plasma membrane upon the addition of IL-6-RFP. The apparent molecular mass of the IL-6.IL-6-RFP complex determined by blue native PAGE and gel filtration suggests that IL-6 is trapped in a structure analogous to the native hexameric IL-6 receptor complex. Thus, fusion of the ligand binding domains of heteromeric receptors leads to highly specific cytokine inhibitors with superior activity compared with the separate soluble receptors.
27
Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
Tetsuya Taga, Masahiko Hibi, Yuuichi Hirata et al. · Cell · 1989 · 1.4K citations
Molecular cloning and expression of an IL-6 signal transducer, gp130
Masahiko Hibi, Masaaki Murakami, Mikiyoshi Saito et al. · Cell · 1990 · 1.3K citations
Production of hybridoma growth factor by human monocytes
Lucien A. Aarden, Els R. de Groot, Otto L. Schaap et al. · European Journal of Immunology · 1987 · 1.1K citations
Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) Receptor
Katsuhiko Yamasaki, Tetsuya Taga, Yuuichi Hirata et al. · Science · 1988 · 1.1K citations